Arsenic Trioxide as Effective Therapy for Relapsed Acute Promyelocytic Leukemia

    Jami Mayorga, Carron Richardson-Hardin, Karel A. Dicke
    Studysummary This article discusses arsenic trioxide as a treatment for refractory or relapsed acute promyelocytic leukemia, noting its effectiveness and manageable side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’